Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AstraZeneca CEO Soriot tops FTSE 100 pay-out charts in 2020 -report

Thu, 19th Aug 2021 00:01

* Soriot took home 15.45 mln stg - High Pay Centre report

* Experian CEO Cassin in second place with 10.3 mln stg

* Median FTSE 100 CEO pay down 17% in pandemic-hit year

By Simon Jessop

LONDON, Aug 19 (Reuters) - Pascal Soriot, the chief
executive of COVID-19 vaccine maker AstraZeneca, was
Britain's highest paid company boss in 2020, a year when the
average FTSE 100 leader saw their pay fall by almost a fifth, a
report on Thursday showed.

Soriot, whose handling of the pandemic response has drawn
criticism despite the company producing its vaccine at cost
price, took home 15.45 million pounds ($21.25 million), a report
from the High Pay Centre said.

That compares with median pay for CEOs in Britain's flagship
stock index of 2.69 million pounds, down from 3.25 million
pounds in 2019, the report found, but still 86 times the median
earnings for the average UK worker.

Shareholders had demanded bosses share the financial pain as
companies across a range of sectors experienced a tough year,
with lockdowns in many countries hitting sales.

The proportion of companies paying bonuses dropped to 64%
from 89% in 2019, while 77% paid out long-term incentives based
on performance over the previous 3-5 years, compared to 82% the
previous year.

Of the nine companies which took public money through the
British government's furlough scheme, the average CEO pay was
2.2 million pounds.

"CEO pay packages are designed to reflect the experience of
shareholders, employees and other stakeholders so in one sense
the lower pay levels this year show the system working as
intended," said High Pay Centre Director Luke Hildyard.

"On the other hand, these are still very generous
rewards...at a time when, in general, government support for the
economy has probably been more important to the survival and
success of the UK's biggest companies than the decisions of
their executives."

Rounding out the top five earners were Experian's Brian
Cassin, with 10.3 million pounds; CRH's Albert Manifold, with
9.92 million pounds; Reckitt Benckiser's Laxman Narasimhan, with
9.24 million pounds, and Berkeley's Rob Perrins, with 8.03
million pounds, the report said.

($1 = 0.7271 pounds)
(Reporting by Simon Jessop; Editing by Kirsten Donovan)

More News
Today 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.